These novel findings suggest a novel role of FGF23 in the pathogenesis of CAVD associated with CKD and point to the therapeutic potential of Klotho for prevention of CAVD development and progression in old CKD subjects with high risks for CAVD and aortic stenosis. This evidence concerns the gene FGF23 and aortic stenosis.